0
     

Report Added
Report already added
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) - Global Forecasts to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) - Global Forecasts to 2027

The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population.
However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period.

“Over-the-counter (OTC) productssegment isestimated to grow at the highest rate during the forecast period”

On the basis ofdrug type, the digital pharmacy market is segmented into prescription medicines and over-the-counter products. Prescription medicines accounted for the largest share of the global digital pharmacy market in 2021. The large share of this market segment can be attributed to factors such as growing prevalence of several chronic disorders and the subsequent growing demand for medications.
On the other hand, the over-the-counter (OTC) products segment isexpected to grow at the highest CAGR during the forecast period. Growth in this market segment is largely driven by the widespread availability and cost-effectiveness of over-the-counter products and the growing trend of self-medication.

“The Medicines & Treatmentssegment is expected to account for the largest share of theDigital Pharmacymarket in 2021”

On the basis ofproducts, the digital pharmacy market is segmented into medicines & treatments, personal care products, vitamins & supplements, and other products. The medicines & treatments segment accounted for the largest share of the global digital pharmacy market in 2021.
However, the vitamins & supplements segment is expected to register the highest CAGR during the forecast period due to increase prevalence of chronic diseases and the availability of multiple product options.

“Appssegment in the platformis expected to account for the largest share of the global digital pharmacy market”

On the basis ofplatforms, the digital pharmacy market is segmented into apps and websites. In 2021, apps is expected to hold the largest share of the global digital pharmacy market, growth in this segment is attributed to factors as the appsoffer lucrative promos or discounts to attract customers.The websitesplatform is estimated to grow at the second-highest CAGR during the forecast period due to convenience, privacy, and safety offered by websites are key factors driving the market growth.

“Captive segmentamong the business model accounted for the largest share of the global digital pharmacy market in 2021”

On the basis ofbusiness models, the digital pharmacy market is segmented into captive, franchise, and aggregator business models. The captive business model accounted for the largest share of the global digital pharmacy market in 2021 The captive business model is also estimated to register the highest CAGR during the forecast period. The flexibility, accessibility, and affordability of captive business models are key factors to segmental growth in the digital pharmacy market. The aggregator business model is estimated to grow at the second-highest CAGR during the forecast period.

“The Urbanareasaccounted for the largest share of the global digital pharmacy market in 2021”

On the basis ofgeographic coverage, the digital pharmacy market is segmented into urban and rural areas. Urban areas accounted for the largest share of the global digital pharmacy market in 2021 due to the growing penetration of the internet in urban areas.

“North America todominate the digital pharmacy market during forecast period”

North America accounted for the largest share of the digital pharmacy market in 2022. The growing prevalence of chronic conditions, the rising number of drug prescriptions resulting from the rapidly growing aging population, and the presence of key market players in the region are the key factors driving the growth of the digital pharmacy market in North America.
The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the growing disease burden, growing patient population, and the rapidly growing pharmaceutical market.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (41%), Tier 2(31%), and Tier 3 (28%)
• By Designation: C-level (44%), Director-level (35%), and Others (21%)
• By Region: North America (46%), Europe (26%), Asia Pacific(18%),Latin America (7%) and Middle East & Africa (3%)

Prominent players in this market are CVS Health (US), Cigna (US), Optum, Inc. (Part of the UnitedHealth Group) (US), Walgreens Co. (US), Walmart Inc. (US), The Kroger Co. (US), Amazon.com, Inc. (US), GoodRx (US), Costco Wholesale Corporation (US), Rite Aid Corp. (US), Hims& Hers Health, Inc. (US), PharmEasy (India), Apollo Pharmacy (India), DocMorris (Netherlands), Giant Eagle Inc. (US), LloydsPharmacy (UK), Shop-apotheke.com (Netherlands), Tata 1mg (India), Netmeds.com (India), HealthWarehouse, Inc. (US), Pharmex Direct Inc. (Canada), Apex Pharmacy (UK), TELUS (Canada), RO Pharmacy (US), Rx Outreach (US), The Independent Pharmacy (UK), Rexall Pharmacy Group ULC (Canada), and NorthWestPharmacy.com (Canada).These players are increasingly focusing on product/service upgrades, acquisitions, partnerships, agreements, expansions, and collaborations to expand their product offerings in the digital pharmacy market.

Research Coverage
•The report studies theDigital Pharmacymarket based on drug type, products,platform,business model,geographic coverage, and region
•The report analyzes factors (such as drivers, restraints, opportunities, andchallenges) affecting the market growth
•The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
•The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total digital pharmacy market
•The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Digital Pharmacy market and provides them information on key market drivers, restraints, challenges, and opportunities.
Table of Contents

1INTRODUCTION27
1.1OBJECTIVES OF THE STUDY27
1.2MARKET DEFINITION27
1.2.1DIGITAL PHARMACY MARKET: INCLUSIONS & EXCLUSIONS27
1.3MARKET SCOPE28
1.3.1MARKETS COVERED28
FIGURE 1DIGITAL PHARMACY MARKET28
1.3.2YEARS CONSIDERED FOR THE STUDY29
1.4CURRENCY29
1.5LIMITATIONS29
1.5.1SCOPE-RELATED LIMITATIONS29
1.6STAKEHOLDERS29
2RESEARCH METHODOLOGY30
2.1RESEARCH DATA30
FIGURE 2RESEARCH DESIGN30
2.1.1SECONDARY DATA31
2.1.1.1Key data from secondary sources32
2.1.2PRIMARY RESEARCH32
2.1.2.1Key industry insights33
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION34
2.2MARKET ESTIMATION34
2.2.1APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)34
2.2.2APPROACH: REVENUE MAPPING-BASED MARKET ESTIMATION35
FIGURE 4MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)36
FIGURE 5RESEARCH METHODOLOGY: HYPOTHESIS BUILDING36
FIGURE 6REVENUE SHARE ANALYSIS ILLUSTRATION FOR CVS HEALTH37
2.2.3TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION38
FIGURE 7DIGITAL PHARMACY MARKET: TOP-DOWN APPROACH38
2.2.4GROWTH FORECAST38
FIGURE 8IMPACT OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ON MARKET GROWTH & CAGR39
FIGURE 9CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS39
2.3MARKET DATA ESTIMATION AND TRIANGULATION40
FIGURE 10DATA TRIANGULATION METHODOLOGY40
2.4ASSUMPTIONS FOR THE STUDY41
2.5LIMITATIONS41
2.6RISK ASSESSMENT42
TABLE 1RISK ASSESSMENT: DIGITAL PHARMACY MARKET42
3EXECUTIVE SUMMARY43
FIGURE 11DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2022 VS. 2027 (USD MILLION)43
FIGURE 12DIGITAL PHARMACY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)44
FIGURE 13DIGITAL PHARMACY MARKET, BY PLATFORM, 2022 VS. 2027 (USD MILLION)44
FIGURE 14DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2022 VS. 2027 (USD MILLION)45
FIGURE 15DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE,
2022 VS. 2027 (USD MILLION)46
FIGURE 16GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET47
4PREMIUM INSIGHTS48
4.1DIGITAL PHARMACY MARKET OVERVIEW48
FIGURE 17GROWING GERIATRIC POPULATION TO DRIVE THE MARKET GROWTH48
4.2DIGITAL PHARMACY MARKET, BY PRODUCT49
FIGURE 18MEDICINES & TREATMENTS ACCOUNTED FOR THE LARGEST SHARE
OF THE DIGITAL PHARMACY MARKET IN 202149
4.3NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG & COUNTRY (2021)49
FIGURE 19PRESCRIPTION MEDICINES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 202149
4.4GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET50
FIGURE 20ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD50
4.5MARKET DYNAMICS51
FIGURE 21DIGITAL PHARMACY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES51
4.5.1DRIVERS52
4.5.1.1Increasing consumer preference toward buying online medicines during and post the COVID-19 pandemic52
TABLE 2TOTAL NUMBER OF CONFIRMED CORONAVIRUS CASES, BY REGION
(AS OF JANUARY 7, 2022)52
4.5.1.2Consolidation in the market and partnerships53
4.5.1.3Growing geriatric population53
TABLE 3GLOBAL OVERVIEW OF THE RISE IN THE AGING POPULATION (MILLION)53
4.5.2RESTRAINTS54
4.5.2.1Growing number of illegal pharmacies54
4.5.2.2Risk of counterfeit drugs54
4.5.2.3Increased risk of drug abuse55
4.5.3OPPORTUNITIES55
4.5.3.1Emerging markets55
4.5.3.2Benefits of E-commerce56
4.5.4CHALLENGES56
4.5.4.1Challenges for patients relying on pharmacists for clinical support56
4.5.4.2Lack of strong national laws worldwide57
4.5.4.3Security and privacy concerns58
4.6VALUE CHAIN ANALYSIS59
4.7ECOSYSTEM ANALYSIS60
4.8PORTER’S FIVE FORCES ANALYSIS60
TABLE 4DIGITAL PHARMACY MARKET: PORTER’S FIVE FORCES ANALYSIS60
4.8.1INTENSITY OF COMPETITIVE RIVALRY61
4.8.2BARGAINING POWER OF SUPPLIERS61
4.8.3BARGAINING POWER OF BUYERS61
4.8.4THREAT FROM SUBSTITUTES61
4.8.5THREAT FROM NEW ENTRANTS61
4.9PRICING & REIMBURSEMENT ANALYSIS61
TABLE 5COMPARISON OF AVERAGE DISCOUNTED PRICES FOR A ONE-MONTH SUPPLY OF DRUGS62
4.10TECHNOLOGY ANALYSIS62
4.10.1MACHINE LEARNING62
4.10.2INTERNET OF THINGS63
4.10.3BLOCKCHAIN63
4.10.4CLOUD COMPUTING63
4.11INDUSTRY TRENDS63
4.11.1ONLINE PRESCRIPTION REFILL63
4.11.2VIRTUAL HEALTHCARE SERVICES64
4.11.3DIGITAL HEALTH DIAGNOSTIC TOOLS64
4.12KEY CONFERENCES & EVENTS IN 2021–202265
4.13REGULATORY ANALYSIS65
4.13.1NORTH AMERICA65
4.13.1.1US65
4.13.1.2Canada66
4.13.2EUROPE66
4.13.3ASIA PACIFIC67
4.13.4REST OF THE WORLD67
TABLE 6APPROACHES OF REGULATORY AUTHORITIES (RA) WORLDWIDE
TO CONTROL MEDICINAL PRODUCT ONLINE SALES67
4.14CASE STUDIES68
4.14.1MAGENTO 2 WEB APP MODERNIZATION68
4.14.1.1Use Case 1: Need to Revamp Online Store68
4.14.2WALMART REACT NATIVE PHARMACY69
4.14.2.1Use Case 2: Need to Rebuild Pharmacy App69
4.15IMPACT OF COVID-19 ON THE DIGITAL PHARMACY MARKET69

5DIGITAL PHARMACY MARKET, BY DRUG TYPE70
5.1INTRODUCTION71
TABLE 7DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)71
5.2PRESCRIPTION MEDICINES71
5.2.1GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN CHRONIC DISEASES TO DRIVE THE DEMAND FOR PRESCRIPTION MEDICATION71
TABLE 8DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2020–2027 (USD MILLION)72
TABLE 9NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION)72
TABLE 10EUROPE: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES,
BY COUNTRY, 2020–2027 (USD MILLION)73
5.3OVER-THE-COUNTER PRODUCTS73
5.3.1EASE OF USE AND CONVENIENCE ASSOCIATED WITH OVER-THE-COUNTER PRODUCTS TO DRIVE MARKET GROWTH73
TABLE 11DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS,
BY REGION, 2020–2027 (USD MILLION)74
TABLE 12NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)74
TABLE 13EUROPE: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)75
6DIGITAL PHARMACY MARKET, BY PRODUCT76
6.1INTRODUCTION77
TABLE 14DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)77
6.2MEDICINES & TREATMENTS77
TABLE 15DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)78
TABLE 16NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION)78
TABLE 17EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS,
BY COUNTRY, 2020–2027 (USD MILLION)78
TABLE 18ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION)79
TABLE 19DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)79
6.2.1DIABETES CARE79
6.2.1.1Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments79
TABLE 20DIGITAL PHARMACY MARKET FOR DIABETES CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)80
6.2.2HEART CARE80
6.2.2.1Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments80
TABLE 21DIGITAL PHARMACY MARKET FOR HEART CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)81
6.2.3ONCOLOGY81
6.2.3.1Increasing prevalence of cancer is a major factor driving the growth of this market segment81
TABLE 22DIGITAL PHARMACY MARKET FOR ONCOLOGY MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)81
6.2.3.2Other medicines & treatments82
TABLE 23DIGITAL PHARMACY MARKET FOR OTHER MEDICINES & TREATMENTS,
BY REGION, 2020–2027 (USD MILLION)82
6.3PERSONAL CARE PRODUCTS82
6.3.1GROWING FOCUS ON PERSONAL HEALTH & HYGIENE TO DRIVE MARKET GROWTH82
TABLE 24DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2020–2027 (USD MILLION)83
TABLE 25NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)83
TABLE 26EUROPE: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS,
BY COUNTRY, 2020–2027 (USD MILLION)83
TABLE 27ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)84
6.4VITAMINS & SUPPLEMENTS84
6.4.1GROWING DEMAND FOR IMMUNITY-ASSOCIATED SUPPLEMENTS IN THE WAKE OF THE COVID-19 PANDEMIC TO DRIVE MARKET GROWTH84
TABLE 28DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY REGION, 2020–2027 (USD MILLION)85
TABLE 29NORTH AMERICA: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION)85
TABLE 30EUROPE: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS,
BY COUNTRY, 2020–2027 (USD MILLION)85
TABLE 31ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION)86
6.5OTHER PRODUCTS86
TABLE 32DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY REGION,
2020–2027 (USD MILLION)86
TABLE 33NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS,
BY COUNTRY, 2020–2027 (USD MILLION)87
TABLE 34EUROPE: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)87
TABLE 35ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS,
BY COUNTRY, 2020–2027 (USD MILLION)87
7DIGITAL PHARMACY MARKET, BY PLATFORM88
7.1INTRODUCTION89
TABLE 36DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)89
7.2APPS89
7.2.1ADVANTAGES SUCH AS CONTACTLESS DELIVERY WILL
DRIVE THE DEMAND FOR APPS89
TABLE 37DIGITAL PHARMACY APPS MARKET, BY REGION, 2020–2027 (USD MILLION)90
TABLE 38NORTH AMERICA: DIGITAL PHARMACY APPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)90
TABLE 39EUROPE: DIGITAL PHARMACY APPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)90
TABLE 40ASIA PACIFIC: DIGITAL PHARMACY APPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)91
7.3WEBSITES91
7.3.1PROMOTIONS, DISCOUNTS, AND OFFERS PROVIDED BY WEBSITES TO DRIVE MARKET GROWTH91
TABLE 41DIGITAL PHARMACY WEBSITES MARKET, BY REGION,
2020–2027 (USD MILLION)92
TABLE 42NORTH AMERICA: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)92
TABLE 43EUROPE: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)92
TABLE 44ASIA PACIFIC: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)93
8DIGITAL PHARMACY MARKET, BY BUSINESS MODEL94
8.1INTRODUCTION95
TABLE 45DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)95
8.2CAPTIVE95
8.2.1FLEXIBILITY, ACCESSIBILITY, AND AFFORDABILITY OF CAPTIVE MODELS—
KEY FACTORS DRIVING MARKET GROWTH95
TABLE 46DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY REGION, 2020–2027 (USD MILLION)96
TABLE 47NORTH AMERICA: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS,
BY COUNTRY, 2020–2027 (USD MILLION)96
TABLE 48EUROPE: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)96
TABLE 49ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS,
BY COUNTRY, 2020–2027 (USD MILLION)97
8.3FRANCHISE97
8.3.1GROWING NUMBER OF PHARMACY FRANCHISES TO DRIVE MARKET GROWTH97
TABLE 50DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY REGION,
2020–2027 (USD MILLION)98
TABLE 51NORTH AMERICA: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS,
BY COUNTRY, 2020–2027 (USD MILLION)98
TABLE 52EUROPE: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS,
BY COUNTRY, 2020–2027 (USD MILLION)98
TABLE 53ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS,
BY COUNTRY, 2020–2027 (USD MILLION)99
8.4AGGREGATOR99
8.4.1QUALITY SERVICES ASSOCIATED WITH AGGREGATOR MODELS TO DRIVE MARKET GROWTH99
TABLE 54DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY REGION, 2020–2027 (USD MILLION)100
TABLE 55NORTH AMERICA: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION)100
TABLE 56EUROPE: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS,
BY COUNTRY, 2020–2027 (USD MILLION)100
TABLE 57ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS,
BY COUNTRY, 2020–2027 (USD MILLION)101
9DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE102
9.1INTRODUCTION103
TABLE 58DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE,
2020–2027 (USD MILLION)103
9.2URBAN AREAS103
9.2.1RAPID INTERNET PENETRATION IN URBAN AREAS TO DRIVE MARKET GROWTH IN THIS SEGMENT103
TABLE 59DIGITAL PHARMACY MARKET IN URBAN AREAS, BY REGION,
2020–2027 (USD MILLION)104
9.3RURAL AREAS104
9.3.1GOVERNMENT INITIATIVES TO FUEL THE DEMAND FOR DIGITAL PHARMACIES IN RURAL AREAS104
TABLE 60DIGITAL PHARMACY MARKET IN RURAL AREAS, BY REGION,
2020–2027 (USD MILLION)105
10DIGITAL PHARMACY MARKET, BY REGION106
10.1INTRODUCTION107
TABLE 61DIGITAL PHARMACY MARKET, BY REGION, 2020–2027 (USD MILLION)107
10.2NORTH AMERICA107
10.2.1IMPACT OF COVID-19 ON THE NORTH AMERICAN DIGITAL
PHARMACY MARKET107
FIGURE 22NORTH AMERICA: DIGITAL PHARMACY MARKET SNAPSHOT108
TABLE 62NORTH AMERICA: DIGITAL PHARMACY MARKET, BY COUNTRY,
2020–2027 (USD MILLION)109
TABLE 63NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)109
TABLE 64NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)109
TABLE 65NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)110
TABLE 66NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)110
TABLE 67NORTH AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)110
TABLE 68NORTH AMERICA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)111
10.2.2US111
10.2.2.1The US is the largest regional market for digital pharmacy, mainly due to the rising prevalence of chronic conditions and the growing number of prescriptions111
TABLE 69US: KEY MACROINDICATORS112
TABLE 70US: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)112
TABLE 71US: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)112
TABLE 72US: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)113
TABLE 73US: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)113
TABLE 74US: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)113
TABLE 75US: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE,
2020–2027 (USD MILLION)114
10.2.3CANADA114
10.2.3.1Rising drug expenditures to propel market growth in Canada114
TABLE 76CANADA: KEY MACROINDICATORS115
TABLE 77CANADA: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)115
TABLE 78CANADA: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)116
TABLE 79CANADA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS,
BY TYPE, 2020–2027 (USD MILLION)116
TABLE 80CANADA: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)116
TABLE 81CANADA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)117
TABLE 82CANADA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE,
2020–2027 (USD MILLION)117
10.3EUROPE117
10.3.1IMPACT OF COVID-19 ON THE EUROPEAN DIGITAL PHARMACY MARKET118
TABLE 83EUROPE: DIGITAL PHARMACY MARKET, BY COUNTRY,
2020–2027 (USD MILLION)118
TABLE 84EUROPE: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)118
TABLE 85EUROPE: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)119
TABLE 86EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS,
BY TYPE, 2020–2027 (USD MILLION)119
TABLE 87EUROPE: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)119
TABLE 88EUROPE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)120
10.3.2GERMANY120
10.3.2.1Germany is the fastest-growing market for digital pharmacies in Europe120
TABLE 89GERMANY: KEY MACROINDICATORS121
TABLE 90GERMANY: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)121
TABLE 91GERMANY: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)121
TABLE 92GERMANY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS,
BY TYPE, 2020–2027 (USD MILLION)122
TABLE 93GERMANY: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)122
TABLE 94GERMANY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)122
10.3.3UK123
10.3.3.1Rising initiatives to improve the safety of digital pharmacies to boost the market growth123
TABLE 95UK: KEY MACROINDICATORS124
TABLE 96UK: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)124
TABLE 97UK: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)124
TABLE 98UK: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 99UK: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)125
TABLE 100UK: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)125
10.3.4FRANCE126
10.3.4.1Rising geriatric population in the country to support market growth126
TABLE 101FRANCE: KEY MACROINDICATORS126
TABLE 102FRANCE: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)126
TABLE 103FRANCE: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)127
TABLE 104FRANCE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS,
BY TYPE, 2020–2027 (USD MILLION)127
TABLE 105FRANCE: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)127
TABLE 106FRANCE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)128
10.3.5ITALY128
10.3.5.1Growing burden of chronic diseases is driving the market
growth in Italy128
TABLE 107ITALY: KEY MACROINDICATORS129
TABLE 108ITALY: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)129
TABLE 109ITALY: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)129
TABLE 110ITALY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS,
BY TYPE, 2020–2027 (USD MILLION)130
TABLE 111ITALY: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)130
TABLE 112ITALY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)130
10.3.6SPAIN131
10.3.6.1Increasing focus on improving the healthcare infrastructure in the country to support market growth131
TABLE 113SPAIN: KEY MACROINDICATORS131
TABLE 114SPAIN: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)132
TABLE 115SPAIN: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)132
TABLE 116SPAIN: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS,
BY TYPE, 2020–2027 (USD MILLION)132
TABLE 117SPAIN: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)133
TABLE 118SPAIN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)133
10.3.7ROE133
TABLE 119ROE: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)134
TABLE 120ROE: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)134
TABLE 121ROE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)135
TABLE 122ROE: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)135
TABLE 123ROE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)135
10.4ASIA PACIFIC136
10.4.1IMPACT OF COVID-19 ON THE ASIA PACIFIC DIGITAL PHARMACY MARKET136
FIGURE 23ASIA PACIFIC: DIGITAL PHARMACY MARKET SNAPSHOT137
TABLE 124ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY COUNTRY,
2020–2027 (USD MILLION)138
TABLE 125ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)138
TABLE 126ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)138
TABLE 127ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)139
10.4.2CHINA139
10.4.2.1Increasing consumer demand for OTC products to drive the market for digital pharmacy in China139
TABLE 128CHINA: KEY MACROINDICATORS140
TABLE 129CHINA: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)140
TABLE 130CHINA: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)140
TABLE 131CHINA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)141
10.4.3JAPAN141
10.4.3.1Rising healthcare expenditures and the growing burden of non-communicable diseases (NCDs) to drive market growth in Japan141
TABLE 132JAPAN: KEY MACROINDICATORS142
TABLE 133JAPAN: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)142
TABLE 134JAPAN: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)142
TABLE 135JAPAN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)143
10.4.4INDIA143
10.4.4.1Favorable government initiatives and high density of rural population to support market growth in India143
TABLE 136INDIA: KEY MACROINDICATORS144
TABLE 137INDIA: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)144
TABLE 138INDIA: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)144
TABLE 139INDIA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS,
BY TYPE, 2020–2027 (USD MILLION)145
TABLE 140INDIA: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)145
TABLE 141INDIA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)145
10.4.5REST OF ASIA PACIFIC146
TABLE 142ROAPAC: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)146
TABLE 143ROAPAC: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)147
TABLE 144ROAPAC: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)147
TABLE 145ROAPAC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)147
10.5LATIN AMERICA148
10.5.1GROWING INTERNET USERS WILL FAVOR MARKET GROWTH IN LATAM148
10.5.1.1Impact of COVID-19 on the Latin American digital pharmacy market148
TABLE 146LATIN AMERICA: KEY MACROINDICATORS149
TABLE 147LATIN AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)149
TABLE 148LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)149
TABLE 149LATIN AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)150
TABLE 150LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)150
TABLE 151LATIN AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)150
10.6MIDDLE EAST & AFRICA151
10.6.1INCREASING DEMAND FOR ONLINE PHARMACEUTICAL PRODUCTS WILL DRIVE THE MARKET IN THE MEA151
10.6.1.1Impact of COVID-19 on the Middle East & Africa digital
pharmacy market152
TABLE 152MEA: DIGITAL PHARMACY MARKET, BY DRUG TYPE,
2020–2027 (USD MILLION)152
TABLE 153MEA: DIGITAL PHARMACY MARKET, BY PRODUCT,
2020–2027 (USD MILLION)152
TABLE 154MEA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)153
TABLE 155MEA: DIGITAL PHARMACY MARKET, BY PLATFORM,
2020–2027 (USD MILLION)153
TABLE 156MEA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL,
2020–2027 (USD MILLION)153
11COMPETITIVE LANDSCAPE154
11.1OVERVIEW154
11.2KEY PLAYER STRATEGIES/RIGHT TO WIN154
11.2.1OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN
THE DIGITAL PHARMACY MARKET154
11.3REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS155
11.4MARKET RANKING156
FIGURE 24US DIGITAL PHARMACY MARKET RANKING, BY KEY PLAYER, 2021156
11.5COMPETITIVE BENCHMARKING157
11.5.1OVERALL COMPANY FOOTPRINT157
TABLE 157OVERALL COMPANY FOOTPRINT157
11.5.2COMPANY DRUG TYPE FOOTPRINT157
TABLE 158COMPANY DRUG TYPE FOOTPRINT157
11.5.3COMPANY PRODUCT FOOTPRINT158
TABLE 159COMPANY PRODUCT FOOTPRINT158
11.5.4COMPANY PLATFORM FOOTPRINT158
TABLE 160COMPANY PLATFORM FOOTPRINT158
11.5.5COMPANY REGIONAL FOOTPRINT159
TABLE 161COMPANY REGIONAL FOOTPRINT159
TABLE 162DIGITAL PHARMACY MARKET: DETAILED LIST OF KEY START-UPS/SMES159
11.6COMPETITIVE LEADERSHIP MAPPING160
11.6.1STARS160
11.6.2EMERGING LEADERS160
11.6.3PERVASIVE PLAYERS160
11.6.4PARTICIPANTS160
FIGURE 25DIGITAL PHARMACY MARKET (GLOBAL)
COMPANY EVALUATION MATRIX, 2021161
11.7COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES162
11.7.1PROGRESSIVE COMPANIES162
11.7.2STARTING BLOCKS162
11.7.3RESPONSIVE COMPANIES162
11.7.4DYNAMIC COMPANIES162
FIGURE 26COMPETITIVE LEADERSHIP MAPPING: START-UP/SME MATRIX MARKET163
11.8COMPETITIVE SITUATIONS AND TRENDS164
11.8.1PRODUCT/SERVICE UPGRADES164
11.8.2DEALS165
11.8.3OTHER DEVELOPMENTS166
12COMPANY PROFILES167
12.1KEY PLAYERS167
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1CVS HEALTH167
TABLE 163CVS HEALTH: BUSINESS OVERVIEW167
FIGURE 27CVS HEALTH: COMPANY SNAPSHOT (2021)168
12.1.2CIGNA170
TABLE 164CIGNA: BUSINESS OVERVIEW170
FIGURE 28CIGNA: COMPANY SNAPSHOT (2021)171
12.1.3OPTUM, INC. (PART OF THE UNITEDHEALTH GROUP)173
TABLE 165OPTUM, INC.: BUSINESS OVERVIEW173
FIGURE 29OPTUM, INC.: COMPANY SNAPSHOT (2021)174
12.1.4WALGREEN CO.176
TABLE 166WALGREEN CO.: BUSINESS OVERVIEW176
FIGURE 30WALGREEN CO.: COMPANY SNAPSHOT (2021)176
12.1.5WALMART INC.179
TABLE 167WALMART INC.: BUSINESS OVERVIEW179
FIGURE 31WALMART INC.: COMPANY SNAPSHOT (2021)180
12.1.6THE KROGER CO.182
TABLE 168THE KROGER CO.: BUSINESS OVERVIEW182
FIGURE 32THE KROGER CO.: COMPANY SNAPSHOT (2020)182
12.1.7GIANT EAGLE, INC.185
TABLE 169GIANT EAGLE, INC.: BUSINESS OVERVIEW185
12.1.8AMAZON.COM, INC.186
TABLE 170AMAZON.COM, INC.: BUSINESS OVERVIEW186
FIGURE 33AMAZON.COM, INC.: COMPANY SNAPSHOT (2020)187
12.1.9PHARMEASY190
TABLE 171PHARMEASY: BUSINESS OVERVIEW190
12.1.10APEX PHARMACY192
TABLE 172APEX PHARMACY: BUSINESS OVERVIEW192
12.1.11APOLLO PHARMACY194
TABLE 173APOLLO PHARMACY: BUSINESS OVERVIEW194
FIGURE 34APOLLO HOSPITAL: COMPANY SNAPSHOT (2021)195
12.1.12RITE AID CORP197
TABLE 174RITE AID CORP.: BUSINESS OVERVIEW197
FIGURE 35RITE AID CORP.: COMPANY SNAPSHOT (2021)197
12.1.13COSTCO WHOLESALE CORPORATION200
TABLE 175COSTCO WHOLESALE CORPORATION: BUSINESS OVERVIEW200
FIGURE 36COSTCO WHOLESALE CORPORATION: COMPANY SNAPSHOT (2021)200
12.2OTHER KEY PLAYERS203
12.2.1SHOP-APOTHEKE.COM203
12.2.2NETMEDS.COM204
12.2.3DOCMORRIS205
12.2.4TATA 1MG206
12.2.5LLOYDSPHARMACY207
12.2.6GOODRX, INC.208
12.2.7HEALTHWAREHOUSE.COM209
12.2.8TELUS HEALTH210
12.2.9PHARMEX DIRECT INC.210
12.2.10HIMS & HERS HEALTH, INC.211
12.2.11RO PHARMACY211
12.2.12RX OUTREACH212
12.2.13THE INDEPENDENT PHARMACY213
12.2.14REXALL PHARMACY GROUP ULC214
12.2.15NORTHWESTPHARMACY.COM215
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13APPENDIX217
13.1DISCUSSION GUIDE217
13.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL221
13.3AVAILABLE CUSTOMIZATIONS223
13.4RELATED REPORTS223
13.5AUTHOR DETAILS224

Report Title: Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) - Global Forecasts to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW